ANTHELMINTIC DRUG DISCOVERY: INTO THE FUTURE

被引:81
|
作者
Geary, Timothy G. [1 ]
Sakanari, Judy A. [1 ]
Caffrey, Conor R. [1 ]
机构
[1] McGill Univ, Inst Parasitol, Quebec City, PQ H9X 3V9, Canada
关键词
SCHISTOSOMA-MANSONI INVITRO; ON-A-CHIP; HIGH-THROUGHPUT; ECHINOCOCCUS-MULTILOCULARIS; ANTIPARASITIC DRUGS; RESISTANCE; BRUGIA; CULTIVATION; WHOLE; 3RD-STAGE;
D O I
10.1645/14-703.1
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The last half-century has provided all of the (few) drugs currently used to treat human helminthiases. Concern regarding the long-term utility of these drugs, given how readily resistance evolves in the veterinary-agricultural sector, spurs the discovery of new chemical entities. We review the approaches and technologies in use to identify anthelmintics and discuss a number of drug discovery paradigms that may prove pivotal to the next half-century of anthelmintic development.
引用
收藏
页码:125 / 133
页数:9
相关论文
共 50 条
  • [41] The future of combinatorial chemistry as a drug discovery paradigm
    Hall, SE
    PHARMACEUTICAL RESEARCH, 1997, 14 (09) : 1104 - 1105
  • [42] Plant Metabolomics: The Future of Anticancer Drug Discovery
    Dabbousy, Ranin
    Rima, Mohamad
    Roufayel, Rabih
    Rahal, Mohamad
    Legros, Christian
    Sabatier, Jean-Marc
    Fajloun, Ziad
    PHARMACEUTICALS, 2024, 17 (10)
  • [43] The future of molecular dynamics simulations in drug discovery
    Borhani, David W.
    Shaw, David E.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2012, 26 (01) : 15 - 26
  • [44] Bromodomain Drug Discovery - the Past, the Present, and the Future
    Pervaiz, Mehrosh
    Mishra, Pankaj
    Guenther, Stefan
    CHEMICAL RECORD, 2018, 18 (12): : 1808 - 1817
  • [45] The future of molecular dynamics simulations in drug discovery
    David W. Borhani
    David E. Shaw
    Journal of Computer-Aided Molecular Design, 2012, 26 : 15 - 26
  • [46] The Future Is Now: Artificial Intelligence in Drug Discovery
    Bajorath, Juergen
    Kearnes, Steven
    Walters, W. Patrick
    Georg, Gunda I.
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (11) : 5249 - 5249
  • [47] The Present and Future of Drug Discovery for Chagas Disease
    Campillo, Nuria E.
    Gonzalez-Naranjo, Pedro
    Antonio Paez, Juan
    ANALES DE LA REAL ACADEMIA NACIONAL DE FARMACIA, 2012, 78 (01): : 34 - 61
  • [48] Drug Discovery for Kinetoplastid Diseases: Future Directions
    Rao, Srinivasa P. S.
    Barrett, Michael P.
    Dranoff, Glenn
    Faraday, Christopher J.
    Gimpelewicz, Claudio R.
    Hailu, Asrat
    Jones, Catherine L.
    Kelly, John M.
    Lazdins-Helds, Jams K.
    Maser, Pascal
    Mengel, Jose
    Mottram, Jeremy C.
    Mowbray, Charles E.
    Sacks, David L.
    Scott, Phillip
    Spath, Gerald F.
    Tarleton, Rick L.
    Spector, Jonathan M.
    Diagana, Thierry T.
    ACS INFECTIOUS DISEASES, 2019, 5 (02): : 152 - 157
  • [49] The future of molecular pharmacology and drug discovery in psychiatry
    Caron, M.
    Urs, N. M.
    Peterson, S. M.
    Snyder, J. C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S108 - S109
  • [50] The impact of genetics on future drug discovery in schizophrenia
    Matsumoto, Mitsuyuki
    Walton, Noah M.
    Yamada, Hiroshi
    Kondo, Yuji
    Marek, Gerard J.
    Tajinda, Katsunori
    EXPERT OPINION ON DRUG DISCOVERY, 2017, 12 (07) : 673 - 686